SwissMedic-2021-0069-V169

Type IA variation for application SwissMedic-2021-0069. Type IA variation: Container Closure Change for Brextanib — critical change

Variation Number
SwissMedic-2021-0069-V169
Type
Type IA
Application
SwissMedic-2021-0069
Change
CHG-2024-0169
Status
Overdue
Fee
€1,625
Submitted
2024-02-04
Approved
—
Description

Type IA variation: Container Closure Change for Brextanib — critical change